MARKET PULSE- Tesco, Regeneron, GSK, Boeing
(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s)
Sept 16 (Reuters) - Some U.S. stocks to watch on Monday:
** PLURISTEM THERAPEUTICS INC, Friday close $3.22, up 8.7 pct premarket
The Israel-based company said the U.S. Food and Drug Administration lifted its clinical hold on a mid-stage trial of the company's experimental drug for muscle pain. Pluristem said the FDA allowed it to go ahead with the study, saying that Pluristem had addressed all issues related to the hold.
** HUNTSMAN CORP, Friday close $19.27, up 1.2 pct after market
Brokerage KeyBanc Capital Markets raised its rating on the chemical maker's stock to "buy" from "hold" on Friday, according to theflyonthewall.com. Jefferies on Monday also upgraded Huntsman to "buy", citing gains in 2014-2015 from its propylene oxide-making joint venture with China's refiner Sinopec Corp , which is expected to be completed by the end of next year and its presence in Europe, among other things.
** BOEING CO, Friday close $111.33
Top decision makers in South Korea's 8.3 trillion won ($7.64 billion) fighter jet tender have briefed the president on the outcome of an assessment process and told her that Boeing Co's F-15 Silent Eagle was the sole eligible bid, a source with knowledge of the process told Reuters.
** GLAXOSMITHKLINE PLC, Friday close $51.41
A combination treatment from the drugmaker for melanoma, the deadliest form of skin cancer, has won priority review from U.S. regulators. The move means the Food and Drug Administration will now decide whether to approve the dual use of Tafinlar, also known as dabrafenib, and Mekinist, or trametinib, by early January.
** REGENERON PHARMACEUTICALS, Friday close $289.96
Sanofi chief executive Chris Viehbacher told an investor conference the group had the resources to do "opportunistic" share buybacks, as well as making bolt-on acquisitions and potentially increasing its stake in U.S. biotech firm Regeneron Pharmaceuticals.
** TESCO CORP, Friday close $16.33
Britain's biggest retailer said the pork it sold as from a British farm probably came from a Dutch one, the latest public relations blow for the company. The firm is attempting to revive its fortunes in its home market after losing share to rivals, but has suffered a series of setbacks this year, including the discovery across Europe of horsemeat in products labelled as beef.
(Compiled by Varun Aggarwal)